PortfoliosLab logoPortfoliosLab logo
PILL vs. XTJL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PILL vs. XTJL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PILL achieves a -1.69% return, which is significantly lower than XTJL's 5.38% return.


PILL

1D
8.24%
1M
-11.70%
YTD
-1.69%
6M
7.86%
1Y
123.35%
3Y*
16.40%
5Y*
-10.52%
10Y*

XTJL

1D
0.02%
1M
1.01%
YTD
5.38%
6M
6.35%
1Y
15.58%
3Y*
14.67%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PILL vs. XTJL - Yearly Performance Comparison


2026 (YTD)20252024202320222021
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
-1.69%75.14%-7.26%-12.06%-43.16%-36.15%
XTJL
Innovator U.S. Equity Accelerated Plus ETF - July
5.38%15.42%14.43%25.72%-15.66%7.28%

Correlation

The correlation between PILL and XTJL is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.45

Correlation (3Y)
Calculated over the trailing 3-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2021

0.58

The correlation between PILL and XTJL shifts across timeframes, from 0.45 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.

PILL vs. XTJL - Sectors Allocation Comparison


Sectors
PILL
XTJL

Healthcare

100.0%
8.4%

Basic Materials

-

1.8%

Communication Services

-

10.9%

Consumer Cyclical

-

10.1%

Consumer Defensive

-

4.9%

Energy

-

3.5%

Financial Services

-

11.9%

Industrials

-

8.1%

Real Estate

-

1.9%

Technology

-

36.2%

Utilities

-

2.3%

Healthcare

PILL
100.0%
XTJL
8.4%

Basic Materials

PILL

-

XTJL
1.8%

Communication Services

PILL

-

XTJL
10.9%

Consumer Cyclical

PILL

-

XTJL
10.1%

Consumer Defensive

PILL

-

XTJL
4.9%

Energy

PILL

-

XTJL
3.5%

Financial Services

PILL

-

XTJL
11.9%

Industrials

PILL

-

XTJL
8.1%

Real Estate

PILL

-

XTJL
1.9%

Technology

PILL

-

XTJL
36.2%

Utilities

PILL

-

XTJL
2.3%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PILL vs. XTJL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PILL
PILL Risk / Return Rank: 6161
Overall Rank
PILL Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
PILL Sortino Ratio Rank: 5252
Sortino Ratio Rank
PILL Omega Ratio Rank: 4949
Omega Ratio Rank
PILL Calmar Ratio Rank: 7575
Calmar Ratio Rank
PILL Martin Ratio Rank: 6868
Martin Ratio Rank

XTJL
XTJL Risk / Return Rank: 7272
Overall Rank
XTJL Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
XTJL Sortino Ratio Rank: 7070
Sortino Ratio Rank
XTJL Omega Ratio Rank: 7979
Omega Ratio Rank
XTJL Calmar Ratio Rank: 6363
Calmar Ratio Rank
XTJL Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PILL vs. XTJL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PILLXTJLDifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

-0.62

Omega ratioGain probability vs. loss probability

1.30

1.46

-0.16

Calmar ratioReturn relative to maximum drawdown

3.74

3.06

+0.68

Martin ratioReturn relative to average drawdown

12.24

17.30

-5.06

PILL vs. XTJL - Sharpe Ratio Comparison

The current PILL Sharpe Ratio is 1.99, which is comparable to the XTJL Sharpe Ratio of 2.11. The chart below compares the historical Sharpe Ratios of PILL and XTJL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PILLXTJLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.99

2.11

-0.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.11

0.65

-0.75

Drawdowns

PILL vs. XTJL - Drawdown Comparison

The maximum PILL drawdown since its inception was -88.76%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for PILL and XTJL.


Loading charts...

Drawdown Indicators


PILLXTJLDifference

Max Drawdown

Largest peak-to-trough decline

-88.76%

-23.24%

-65.52%

Max Drawdown (1Y)

Largest decline over 1 year

-33.21%

-5.12%

-28.09%

Max Drawdown (3Y)

Largest decline over 3 years

-60.43%

-16.70%

-43.73%

Max Drawdown (5Y)

Largest decline over 5 years

-83.38%

Current Drawdown

Current decline from peak

-66.31%

0.00%

-66.31%

Average Drawdown

Average peak-to-trough decline

-58.54%

-4.04%

-54.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.12%

0.90%

+9.22%

Volatility

PILL vs. XTJL - Volatility Comparison

Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) has a higher volatility of 22.02% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.31%. This indicates that PILL's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PILLXTJLDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.02%

0.31%

+21.71%

Volatility (6M)

Calculated over the trailing 6-month period

48.70%

5.72%

+42.98%

Volatility (1Y)

Calculated over the trailing 1-year period

62.21%

7.42%

+54.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.53%

15.21%

+45.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.83%

15.21%

+48.62%

PILL vs. XTJL - Expense Ratio Comparison

PILL has a 0.98% expense ratio, which is higher than XTJL's 0.79% expense ratio.


Dividends

PILL vs. XTJL - Dividend Comparison

PILL's dividend yield for the trailing twelve months is around 0.64%, while XTJL has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
0.64%0.69%1.28%1.83%0.67%0.00%0.00%0.38%0.91%0.10%
XTJL
Innovator U.S. Equity Accelerated Plus ETF - July
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


PILL and XTJL have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PILL has higher volatility (22.02%) compared to XTJL (0.31%). In terms of maximum drawdown, PILL dropped -88.76% vs XTJL's -23.24%.

On 3-year performance, PILL leads with 16.40% vs 14.67% for XTJL. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.31%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, PILL has performed better with a 16.40% return vs 14.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XTJL is cheaper with a 0.79% expense ratio, compared with 0.98% for PILL.

PILL has the higher dividend yield at 0.64%, compared with 0.00% for XTJL.

They also come from different issuers: Direxion and Innovator. Their fees differ too: 0.98% for PILL and 0.79% for XTJL.

XTJL currently has the higher Sharpe Ratio (2.11 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PILL and XTJL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer